Named on 2 rounds in the feed, most often at Series B.
Rounds from 2024-10-22 to 2026-11-08
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$243.7M
across 2 rounds
CO-INVESTORS
22
named beside it
Named on 2 rounds in the feed, most often at Series B.
Rounds from 2024-10-22 to 2026-11-08
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
newmo A taxi and autonomous taxi development company | Series B Verified against 4 of 7 sources | $131.7M | 2026-11-08 | [ PART ] |
AvenCell Therapeutics A privately held clinical-stage company developing CAR-T therapies | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $112M | 2024-10-22 | [ PART ] |